Overview

Naturalistic Study of Microdosing With Psilocybin

Status:
Completed
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This study seeks to understand the neural, cognitive and behavioral effects of low doses of psilocybin administered in the form of dried mushroom material (0.5 g of Psilocybe cubensis) consumed in natural settings following a placebo-controlled double-blind experimental design.
Phase:
N/A
Details
Lead Sponsor:
National Council of Scientific and Technical Research, Argentina
Treatments:
Psilocybin